Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 4
2005 3
2006 1
2007 1
2010 4
2011 2
2013 2
2014 2
2015 4
2016 1
2017 4
2018 3
2019 2
2020 5
2021 5
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia.
Ottone T, Faraoni I, Fucci G, Divona M, Travaglini S, De Bellis E, Marchesi F, Angelini DF, Palmieri R, Gurnari C, Giansanti M, Nardozza AM, Montesano F, Fabiani E, Lindfors Rossi EL, Cerretti R, Cicconi L, De Bardi M, Catanoso ML, Battistini L, Massoud R, Venditti A, Voso MT. Ottone T, et al. Front Oncol. 2022 Jun 27;12:890344. doi: 10.3389/fonc.2022.890344. eCollection 2022. Front Oncol. 2022. PMID: 35832559 Free PMC article.
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
Banella C, Catalano G, Travaglini S, Pelosi E, Ottone T, Zaza A, Guerrera G, Angelini DF, Niscola P, Divona M, Battistini L, Screnci M, Ammatuna E, Testa U, Nervi C, Voso MT, Noguera NI. Banella C, et al. Cancers (Basel). 2022 May 23;14(10):2565. doi: 10.3390/cancers14102565. Cancers (Basel). 2022. PMID: 35626170 Free PMC article.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Travaglini S, Ottone T, Angelini DF, Fiori V, Dominici S, Noguera NI, Śniegocka M, Antonelli S, Irno Consalvo MA, De Bardi M, Banella C, Divona M, Marchesi F, Masciarelli S, Fazi F, Pieraccioli M, Palmieri R, De Angelis G, Buccisano F, Venditti A, Battistini L, Magnani M, Voso MT. Travaglini S, et al. Leukemia. 2022 Jun;36(6):1685-1688. doi: 10.1038/s41375-022-01566-5. Epub 2022 Apr 14. Leukemia. 2022. PMID: 35422094 No abstract available.
Nanovesicles released by OKT3 hybridoma express fully active antibodies.
Logozzi M, Di Raimo R, Properzi F, Barca S, Angelini DF, Mizzoni D, Falchi M, Battistini L, Fais S. Logozzi M, et al. Among authors: angelini df. J Enzyme Inhib Med Chem. 2021 Dec;36(1):175-182. doi: 10.1080/14756366.2020.1852401. J Enzyme Inhib Med Chem. 2021. PMID: 33404266 Free PMC article.
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy.
Di Rita A, Angelini DF, Maiorino T, Caputo V, Cascella R, Kumar M, Tiberti M, Lambrughi M, Wesch N, Löhr F, Dötsch V, Carinci M, D'Acunzo P, Chiurchiù V, Papaleo E, Rogov VV, Giardina E, Battistini L, Strappazzon F. Di Rita A, et al. Among authors: angelini df. Cell Death Differ. 2021 Aug;28(8):2499-2516. doi: 10.1038/s41418-021-00766-3. Epub 2021 Mar 15. Cell Death Differ. 2021. PMID: 33723372 Free PMC article.
Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals.
De Marco L, D'Orso S, Pirronello M, Verdiani A, Termine A, Fabrizio C, Capone A, Sabatini A, Guerrera G, Placido R, Sambucci M, Angelini DF, Giannessi F, Picozza M, Caltagirone C, Salvia A, Volpe E, Balice MP, Rossini A, Rötzschke O, Giardina E, Battistini L, Borsellino G. De Marco L, et al. Among authors: angelini df. JAMA Netw Open. 2022 Apr 1;5(4):e2210871. doi: 10.1001/jamanetworkopen.2022.10871. JAMA Netw Open. 2022. PMID: 35452102 Free PMC article.
47 results